Perth-based biotechnology company pSivida Ltd has completed enrolment for the first studies of absorption, distribution and metabolism of its diabetic macular edema treatment Medidur, the company has announced.
09/10/2007 - 09:12
pSivida opens enrolments for macular edema treatment trials
09/10/2007 - 09:12
